Recro Pharma, Inc.

Good day, ladies and gentlemen, and welcome to the RECRO fourth quarter and year-end 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. As a reminder, this conference call may be recorded. I would now like to hand the conference over to Stephanie Diaz of RECRO's Investor Relations Group. Please go ahead.

Thank you. Hello and thank you for joining us. On today's call, we have David Enloe, President and CEO, and Ryan Lake, Chief Financial Officer. Today, we'll be providing an overview of RECRO's contract development and manufacturing business, including updates on corporate activities and financial results for the quarter and year ended December 31st, 2021. After our prepared remarks, we will welcome your questions. Before we begin, I'd like to caution that comments made during this conference call today, March 1st, 2022, will contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 concerning the current beliefs of the company, which involve a number of assumptions, risks, and uncertainties. Actual results could differ from these statements, and the company undertakes no obligation to revise or update any statement made today. I encourage you to review all of the company's filings with the Securities and Exchange Commission concerning these and other matters. Our earnings press release and this call will include discussion of certain non-GAAP information. You can find our earnings press release, including relevant non-GAAP reconciliations, on our corporate website at RecroCDMO.com. With that, I'll turn the call over to David Edelow, Recro's President and CEO.

Thank you, Stephanie, and thank you to everyone who has dialed in and to those who are participating today via webcast. and I'm on slide three now of the accompanying deck. One year ago, I hosted my first earnings call as Recro's new CEO, having been on board less than three months. At that time, I announced a new strategic vision for the company comprised of four areas of focus for 2021, including expansion and diversification of Recro's customer base, strengthening of our balance sheet position in order to better support both organic and inorganic growth, augmentation of our leadership as well as restructuring our operational organization, and finally, continuing to upgrade and expand our capabilities and facilities to support growing customer demand. I had great optimism at that time, and I'm very pleased to report that we've made great progress with each of these goals during 2021. Our success over the last year has placed the company on a new and exciting trajectory for 2022. I will provide a review of our 2021 achievements, as well as our vision for 2022, following an overview of our Q4 and full year financial results. For that, I'll turn the call over to Ryan.